IPO Premiums
IPO calendar
KAListed

KRM Ayurveda Limited

Bookbuilding IPO · NSE

Price band
₹128 - ₹135
Lot size
1,000 shares
Issue amount
₹77.49 cr
Total subscription
74.43×
Current price₹302
Listing price ₹172.1
Watch live price ↗
Opens
21 Jan 2026
Closes
23 Jan 2026
Allotment
27 Jan 2026
Listing
29 Jan 2026

Offer at a glance

Issue overview

Issue size
57,40,000 shares
Face value
₹10 per share
Minimum investment
₹1,28,000
Fresh issue
₹77.49 cr
Offer for sale
₹0 cr
Registrar
Skyline Financial Services Private Limited
Listing exchange
NSE
Maximum investment
₹1,35,000
Issue type
Bookbuilding IPO
Shares before issue
1,55,20,800
Shares after issue
2,12,60,800

Lot sizes

CategoryLotsSharesAmount
Retail22,000₹2,70,000
sHNI33,000₹4,05,000
bHNI88,000₹10,80,000

Share reservation

ANCHOR26.86%
QIB17.98%
HNI13.59%
RETAIL31.57%
Market Maker10%

Subscription & GMP

Subscription by category

Total subscribed74.43×

Reported 23 Jan 2026

QIB63.31×
NIB136.1×
RETAIL54.21×
HNIs(10L+)167.63×
HNIs(2-10L)73.04×

GMP history

08.51713 Jan: ₹022 Jan: ₹1222 Jan: ₹1323 Jan: ₹1228 Jan: ₹1728 Jan: ₹15
13 Jan₹1528 Jan

Day-wise demand

21 Jan1.23×
22 Jan3.77×
23 Jan74.43×

Application-wise demand

CategoryReserved applicationsApplied applications
QIB058
NIB016,637
RETAIL90649,111
HNIs(10L +)17310,615
HNIs (2-10L)876,022

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs13.93882.06
FIIs0131.37
FIs014.05
Mutual Funds00.09
Others0736.55
RETAIL24.461,326
HNIs 2+3.51256.37
HNIs 10+7.021,176.78

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
050100Mar-23 · Revenue: 89.38Mar-23 · Profit after tax: 7.6Mar-23Mar-24 · Revenue: 67.57Mar-24 · Profit after tax: 3.41Mar-24Mar-25 · Revenue: 76.95Mar-25 · Profit after tax: 12.1Mar-25Sep-25 · Revenue: 48.65Sep-25 · Profit after tax: 8.14Sep-25
RevenueProfit after tax

Key performance indicators

MetricSep-25Mar-25Mar-24
EPS000
ROE21.8467.8633.88
ROCE21.8443.3320.8
RONW5.248.062.27
PRE IPO(PE)017.320
POST IPO(PE)23.7300

Values and labels as reported in the issue data.

Peer comparison

CompanyP/E(X)CMP* (₹)Face value (₹)NAV/Share (₹)RONW(%)EPS (Basic) (₹)
KRM Ayurveda Limited17.32135.0010.0025.6427.135.24
Jeena Sikho Lifecare Limited76.58678.502.00142.2431.288.86
Vaidya Sane Ayurved Laboratories Limited93.20286.0010.0059.855.123.07

Company information

Company profile

Incorporated on 3 September 2019, KRM Ayurveda Ltd operates a network of hospitals and clinics across several cities in India and has also expanded its presence internationally through telemedicine consultations and online sales. The company is engaged in manufacturing Ayurvedic products, including herbal and botanical remedies, medicines, supplements, and wellness or skincare-related items. Currently, it manages six hospitals and five clinics at different locations in the country, offers teleconsultation services, and sells KRM Ayurveda products, with a total workforce of 429 employees across various departments as of August 31, 2025.

Strengths

  • Qualified Ayurvedic Professionals: Experienced doctors and certified therapists ensure consistent treatment quality.
  • GMP-Certified Manufacturing: Centralized GMP facility ensures safe and effective Ayurvedic medicines.
  • Trusted Brand & Repeat Clients: Strong patient trust leads to recurring business and brand strength.

Risk factors

  • Non-Ownership of Premises: Operations run from leased hospitals and offices, and relocation could disrupt services.
  • Employee Attrition Risk: High attrition among frontline and technical staff may affect service quality and growth.
  • Geographical Revenue Concentration: Dependence on two key states increases exposure to regional risks.

Promoters

Mr. Puneet Dhawan

Mrs. Tanya Dhawan

Registrar & documents

Lead manager

NEXGEN Financial Solutions Private Limited

Registered office

A-16 G T Karnal road North West Delhi, New Delhi, 110033

+91- 9289101700

[email protected]Company website ↗

Frequently Asked Questions

What is KRM Ayurveda IPO GMP today?

As of today, KRM Ayurveda IPO Grey Market Premium (GMP) is reported at +₹17 per share. Based on the upper price band of ₹135, the estimated listing price is ₹152 (+12.6% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for KRM Ayurveda IPO?

The minimum bid lot size for KRM Ayurveda IPO is 1,000 shares. At the cut-off price of ₹135 per share, retail investors need a minimum application amount of ₹1,35,000 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will KRM Ayurveda IPO allotment status be announced?

The allotment status for KRM Ayurveda IPO is scheduled to be finalized on 27 Jan 2026. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Skyline Financial Services Private Limited's official portal or via BSE/NSE allotment portals.

How can I check KRM Ayurveda IPO allotment status online by PAN?

To check KRM Ayurveda IPO allotment status: 1) Visit the registrar portal (Skyline Financial Services Private Limited) or the BSE IPO allotment page. 2) Select 'KRM Ayurveda Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.